Amicus Therapeutics

343 people · 0 jobs
‌

Amicus Therapeutics, Inc. is a biotechnology company. The Company is engaged in the discovery, development and commercialization of a set of treatments for patients living with devastating rare and orphan diseases.


Org chart

Bradley L. Campbell
President & CEO
Collapse
Jayne C. Gershkowitz
Chief Patient Advocate Emerita
Jeffrey P. Castelli
Chief Portfolio Officer and Head of Gene Therapy
Jill Weimer
Chief Science Officer
Pat Osullivan
Chief Technical Operations Officer
Sam Pierre-Louis
SVP Chief Information Officer
Jordan Masanoff
Senior Director, Business Development & Portfolio Planning
Mike Keavany
President, US Business And Head, Global Marketing
David Clark
Chief People Officer
Jeff Castelli
Chief Development Officer
Gwendolyn Whitney
President, Head Of US Business
Ryan Graham
Executive Director
Ellen S. Rosenberg
Chief Legal Officer

Board & advisors